Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Lancet Neurol. 2013 Mar 29;12(5):435–442. doi: 10.1016/S1474-4422(13)70061-9

B. Adverse events in Re-Enrolled Subjects*

Adverse Event Term 1st Enrollment
N=21
%, n (# events)
2st Enrollment
N= 9
%, n (# events)
3rd Enrollment
N=2
% (# events)
Post-LP Syndrome 48%, 10 (12) 11%, 1 (1) 0%, 0 (0)
Back Pain 29%, 6 (6) 22%, 2 (2) 0%, 0 (0)
Nausea 14%, 3 (3) 0%, 0 (0) 0%, 0 (0)
Headache 10%, 2 (2) 11%, 1 (1) 0%, 0 (0)
*

adverse events listed are those that occurred with a frequency >7% (i.e. occurring in >2 enrollments).